{"id":"https://openalex.org/W4308976875","doi":"https://doi.org/10.1093/neuonc/noac209.236","title":"CTIM-04. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","display_name":"CTIM-04. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308976875","doi":"https://doi.org/10.1093/neuonc/noac209.236"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noac209.236","doi":"https://doi.org/10.1093/neuonc/noac209.236","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.236","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii60/47019343/noac209.236.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii60/47019343/noac209.236.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035416012","display_name":"Manmeet Singh Ahluwalia","orcid":"https://orcid.org/0000-0003-3794-9511","observed_orcids":["https://orcid.org/0000-0003-3794-9511"]},"institutions":[{"id":"https://openalex.org/I1292848113","display_name":"Baptist Hospital of Miami","ror":"https://ror.org/000pfrh90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292848113","https://openalex.org/I4210097785"]},{"id":"https://openalex.org/I4210097785","display_name":"Baptist Health South Florida","ror":"https://ror.org/00v47pv90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210097785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manmeet Ahluwalia","raw_affiliation_strings":["Miami Cancer Institute, Baptist Health South Florida , Miami, FL , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Miami Cancer Institute, Baptist Health South Florida , Miami, FL , USA","institution_ids":["https://openalex.org/I1292848113","https://openalex.org/I4210097785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109012115","display_name":"Neha Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neha Patel","raw_affiliation_strings":["Cleveland Clinic , Cleveland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic , Cleveland , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054741163","display_name":"Atulya Aman Khosla","orcid":"https://orcid.org/0000-0002-8373-4290","observed_orcids":["https://orcid.org/0000-0002-8373-4290"]},"institutions":[{"id":"https://openalex.org/I1292848113","display_name":"Baptist Hospital of Miami","ror":"https://ror.org/000pfrh90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292848113","https://openalex.org/I4210097785"]},{"id":"https://openalex.org/I4210097785","display_name":"Baptist Health South Florida","ror":"https://ror.org/00v47pv90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210097785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atulya Khosla","raw_affiliation_strings":["Miami Cancer Institute, Baptist Health South Florida , Miami, FL , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Miami Cancer Institute, Baptist Health South Florida , Miami, FL , USA","institution_ids":["https://openalex.org/I1292848113","https://openalex.org/I4210097785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113967646","display_name":"Yasmeen Rauf","orcid":"https://orcid.org/0000-0002-3849-7150","observed_orcids":["https://orcid.org/0000-0002-3849-7150"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmeen Rauf","raw_affiliation_strings":["University of North Carolina , North Carolina , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina , North Carolina , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016811839","display_name":"Glen H. J. Stevens","orcid":"https://orcid.org/0000-0002-0106-8483","observed_orcids":["https://orcid.org/0000-0002-0106-8483"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glen Stevens","raw_affiliation_strings":["Cleveland Clinic , Cleveland, OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079216912","display_name":"Erin Sennett Murphy","orcid":"https://orcid.org/0000-0003-3724-8539","observed_orcids":["https://orcid.org/0000-0003-3724-8539","https://orcid.org/0000-0003-3864-1674"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Murphy","raw_affiliation_strings":["Cleveland Clinic , Cleveland, OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058440874","display_name":"Samuel T. Chao","orcid":"https://orcid.org/0000-0002-1087-2764","observed_orcids":["https://orcid.org/0000-0002-1087-2764"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Chao","raw_affiliation_strings":["Cleveland Clinic , Cleveland, OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033599840","display_name":"Jennifer S. Yu","orcid":"https://orcid.org/0000-0002-0244-4014","observed_orcids":["https://orcid.org/0000-0002-0244-4014"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Yu","raw_affiliation_strings":["Cleveland Clinic , Cleveland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic , Cleveland , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087295298","display_name":"John H. Suh","orcid":"https://orcid.org/0000-0001-9523-2637","observed_orcids":["https://orcid.org/0000-0001-9523-2637"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Suh","raw_affiliation_strings":["Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075490964","display_name":"David M. Peereboom","orcid":"https://orcid.org/0000-0001-7798-5176","observed_orcids":["https://orcid.org/0000-0001-7798-5176"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Peereboom","raw_affiliation_strings":["Cleveland Clinic - Richard E. Jacobs Health Center , Cleveland, OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic - Richard E. Jacobs Health Center , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"Supplement_7","first_page":"vii60","last_page":"vii60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9520000219345093},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.902999997138977},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.7960000038146973},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7829999923706055},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.75},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.7329999804496765},{"id":"https://openalex.org/keywords/self-renewal","display_name":"self-renewal","score":0.6759999990463257},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9278318881988525},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8537098169326782},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.688227653503418},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5299488306045532},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5044633150100708},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3583385944366455},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33538466691970825},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.281546026468277},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.13731461763381958}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noac209.236","doi":"https://doi.org/10.1093/neuonc/noac209.236","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.236","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii60/47019343/noac209.236.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9660754","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9660754","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noac209.236","doi":"https://doi.org/10.1093/neuonc/noac209.236","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.236","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii60/47019343/noac209.236.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308976875.pdf","grobid_xml":"https://content.openalex.org/works/W4308976875.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3112847481","https://openalex.org/W4388589559","https://openalex.org/W4379283542","https://openalex.org/W2345226268","https://openalex.org/W2027575682","https://openalex.org/W2586534158","https://openalex.org/W3111733976","https://openalex.org/W1597511577","https://openalex.org/W2604501306","https://openalex.org/W7162667189"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"Glioblastoma":[2,88],"is":[3,19,45,89,271],"associated":[4],"with":[5,8,83,101,173,199,252,275],"dismal":[6],"outcomes":[7,280],"a":[9,46,79,90,200],"survival":[10,185,188],"of":[11,53,76,81,128,171,203,258,269],"15-18":[12],"months.":[13],"A":[14],"major":[15],"challenge":[16],"in":[17,87,118,218,233,254,264],"glioblastoma":[18],"the":[20,31,166],"inability":[21],"to":[22,38,70,120],"effectively":[23],"target":[24],"glioma":[25],"stem":[26],"cells":[27],"(GSCs)":[28],"that":[29],"have":[30],"capacity":[32],"for":[33],"self-renewal.":[34],"GSCs":[35],"are":[36,189],"resistant":[37],"radiation":[39,84,104,123,174,253],"and":[40,58,73,85,122,143,156,158,177,180,186,228,246,277,282],"traditional":[41],"chemotherapy":[42],"agents.":[43],"Ibrutinib":[44,121,129,153,172,248,270],"first-in-class,":[47],"potent,":[48],"small-molecule":[49],"tyrosine":[50,65],"kinase":[51,66],"inhibitor":[52],"Bruton\u2019s":[54],"Tyrosine":[55],"Kinase":[56],"(BTK)":[57],"Bone":[59],"marrow":[60],"X-linked":[61],"(BMX).":[62],"BMX":[63],"nonreceptor":[64],"activates":[67],"STAT3":[68],"signaling":[69],"maintain":[71],"self-renewal":[72],"tumorigenic":[74],"potential":[75],"GSCs.":[77],"Hence":[78],"combination":[80],"ibrutinib":[82,99,157,261],"temozolomide":[86,159,181],"promising":[91],"approach.":[92],"METHODS":[93],"Unmethylated":[94],"MGMT":[95,110],"GBM":[96],"patients":[97,112,194],"received":[98,113,151],"daily":[100,142,274],"60":[102],"Gy":[103],"over":[105],"6":[106],"weeks":[107],"(Arm":[108,124,154,160,175,182],"1).":[109],"methylated":[111],"Temozolomide":[114,276],"at":[115],"75":[116],"mg/m2":[117],"addition":[119],"2).":[125,161,183],"Starting":[126],"dose":[127,138,144,169],"(level":[130],"1)":[131,155],"was":[132,139,147,249,262],"420":[133,259,272],"mg":[134,141,260,273],"daily,":[135],"level":[136,145],"2":[137,235],"560":[140],"-1":[146],"280":[148],"mg.":[149],"Patients":[150],"adjuvant":[152],"The":[162],"primary":[163],"endpoint":[164],"included":[165,221,236],"maximum":[167],"tolerated":[168],"(MTD)":[170],"1),":[176],"ibrutinib,":[178],"radiation,":[179],"Progression-free":[184],"overall":[187],"secondary":[190],"endpoints.":[191],"RESULTS":[192],"27":[193],"(15":[195],"males,":[196],"12":[197],"females),":[198],"median":[201],"age":[202],"63":[204],"years":[205],"(range,":[206],"34-77":[207],"years)":[208],"were":[209],"treated":[210],"on":[211],"two":[212],"arms.":[213],"Dose":[214],"Limiting":[215],"toxicity":[216],"(DLT)":[217],"Arm":[219,234,255,265],"1":[220],"grade":[222,225,229,237,240,243],"3":[223,238,241],"weakness,":[224],"4":[226,230,244],"transaminases,":[227,242],"neutropenia.":[231],"DLT":[232],"rash,":[239],"neutropenia,":[245],"thrombocytopenia.":[247],"too":[250],"toxic":[251],"1,":[256],"MTD":[257,268],"confirmed":[263],"2.":[266],"CONCLUSION":[267],"radiation.":[278],"Efficacy":[279],"(PFS":[281],"OS)":[283],"will":[284],"be":[285],"presented.":[286]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-20T00:00:00"}